Name:
Adduct:
Polarity:
Z:
m/z:
±:
CCS: Å2
±: %
SMI:
Type:

Make a CSV file containing information about your queries.
Then upload the CSV file below and click on "Make Queries" to view the results online
and click "Download Results" to download the entire results in one excel file.
An example of the CSV file can be found below

Download Example CSV


**Make sure the header column names are as follows**

...



Upload a CSV file

1
May, J. C. et al. Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer. Anal. Chem. 86, 2107–2116 (2014).


2
Paglia, G. et al. Ion Mobility Derived Collision Cross Sections to Support Metabolomics Applications. Anal. Chem. 86, 3985–3993 (2014).


3
Groessl, M., Graf, S. & Knochenmuss, R. High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids. Analyst 140, 6904–6911 (2015).


4
Zhou, Z., Shen, X., Tu, J. & Zhu, Z.-J. Large-Scale Prediction of Collision Cross-Section Values for Metabolites in Ion Mobility-Mass Spectrometry. Anal. Chem. 88, 11084–11091 (2016).


5
Hines, K. M., Herron, J. & Xu, L. Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics. The Journal of Lipid Research 58, 809–819 (2017).


6
Bijlsma, L. et al. Prediction of Collision Cross-Section Values for Small Molecules: Application to Pesticide Residue Analysis. Anal. Chem. 89, 6583–6589 (2017).


7
Hines, K. M., Ross, D. H., Davidson, K. L., Bush, M. F. & Xu, L. Large-Scale Structural Characterization of Drug and Drug-Like Compounds by High-Throughput Ion Mobility-Mass Spectrometry. Anal. Chem. 89, 9023–9030 (2017).


8
Stow, S. M. et al. An Interlaboratory Evaluation of Drift Tube Ion Mobility–Mass Spectrometry Collision Cross Section Measurements. Anal. Chem. 89, 9048–9055 (2017).


9
Zhou, Z., Tu, J., Xiong, X., Shen, X. & Zhu, Z.-J. LipidCCS: Prediction of Collision Cross-Section Values for Lipids with High Precision To Support Ion Mobility–Mass Spectrometry-Based Lipidomics. Anal. Chem. 89, 9559–9566 (2017).


10
Zheng, X. et al. A structural examination and collision cross section database for over 500 metabolites and xenobiotics using drift tube ion mobility spectrometry. Chem. Sci. 8, 7724–7736 (2017).


11
Hines, K. M. et al. Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics. mSphere 2, 99–16 (2017).


12
Lian, R. et al. Ion mobility derived collision cross section as an additional measure to support the rapid analysis of abused drugs and toxic compounds using electrospray ion mobility time-of-flight mass spectrometry. Anal. Methods 10, 749–756 (2018).


13
Mollerup, C. B., Mardal, M., Dalsgaard, P. W., Linnet, K. & Barron, L. P. Prediction of collision cross section and retention time for broad scope screening in gradient reversed-phase liquid chromatography-ion mobility-high resolution accurate mass spectrometry. Journal of Chromatography A 1542, 82–88 (2018).


14
Righetti, L. et al. Ion mobility-derived collision cross section database: Application to mycotoxin analysis. Analytica Chimica Acta 1014, 50–57 (2018).


15
Tejada-Casado, C. et al. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs. Analytica Chimica Acta 1043, 52–63 (2018).


16
Nichols, C. M. et al. Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry. Anal. Chem. 90, 14484–14492 (2018).


17
Hines, K. M. & Xu, L. Lipidomic consequences of phospholipid synthesis defects in Escherichia coli revealed by HILIC-ion mobility-mass spectrometry. Chemistry and Physics of Lipids 219, 15–22 (2019).


18
Leaptrot, K. L., May, J. C., Dodds, J. N. & McLean, J. A. Ion mobility conformational lipid atlas for high confidence lipidomics. Nature Communications 1–9 (2019).


19
Blaženović, I. et al. Increasing Compound Identification Rates in Untargeted Lipidomics Research with Liquid Chromatography Drift Time–Ion Mobility Mass Spectrometry. Anal. Chem. 90, 10758–10764 (2018).


20
Tsugawa, H. et al. A lipidome atlas in MS-DIAL 4, Nat. Biotechnol., 38(10):1159-1163 (2020). doi: 10.1038/s41587-020-0531-2.


21
Poland, J. C. et al. Collision Cross Section Conformational Analyses of Bile Acids via Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry 31, 1625–1631 (2020).


22
Dodds, J. et al. Rapid Characterization of Per- and Polyfluoroalkyl Substances (PFAS) by Ion Mobility Spectrometry−Mass Spectrometry (IMS-MS). Anal. Chem. 92, 4427-4435 (2020).


23
Celma, A. et al. Improving Target and Suspect Screening High-Resolution Mass Spectrometry Workflows in Environmental Analysis by Ion Mobility Separation. Environ. Sci. Technol. 54, 15120-15131 (2020)


24
Belova, L. et al. Ion Mobility-High-Resolution Mass Spectrometry (IM-HRMS) for the Analysis of Contaminants of Emerging Concern (CECs): Database Compilation and Application to Urine Samples. Anal. Chem. 93, 6428–6436 (2021)


25
Ross, D. H., et al. High-Throughput Measurement and Machine Learning-Based Prediction of Collision Cross Sections for Drugs and Drug Metabolites. J Am Soc Mass Spectr 33, 1061–1072 (2022).


26
EH Palm, J Engelhardt, S Tshepelevitsh, J Weiss, A Kruve (2024) J Am Soc Mass Spectrom, 35, 1021–1029. DOI:10.1021/jasms.4c00035


27
Baker, E. S. et al. METLIN-CCS Lipid Database: An authentic standards resource for lipid classification and identification Nat. Metab. 6, 981-982 (2024).


28
HB Muller, G Scholl, J Far, E de Pauw, G Eppe (2023) Anal Chem 95(48): 17586-17594


29
Song, X.-C. et al. A Collision Cross Section Database for Extractables and Leachables from Food Contact Materials. J. Agric. Food Chem. 70, 4457–4466 (2022).


30
Nguyen, R. et al. ToxBase: A Multidimensional ToxCast Reference Database for High-Throughput Human Exposome Analysis. Environ. Sci. Technol. (2026).


31
Picache, J. A. et al. Collision Cross Section Compendium to Annotate and Predict Multi-Omic Compound Identities. Chem. Sci. 10, 983–993 (2019).


32
Hines, K. M., May, J. C., McLean, J. A. & Xu, L. Evaluation of Collision Cross Section Calibrants for Structural Analysis of Lipids by Traveling Wave Ion Mobility-Mass Spectrometry. Anal. Chem. 88, 7329–7336 (2016).


33
Dodds, J. N., May, J. C. & McLean, J. A. Investigation of the Complete Suite of the Leucine and Isoleucine Isomers: Toward Prediction of Ion Mobility Separation Capabilities. Anal. Chem. 89, 952–959 (2017).


34
May, J. C. et al. Conformational Landscapes of Ubiquitin, Cytochrome c, and Myoglobin: Uniform Field Ion Mobility Measurements in Helium and Nitrogen Drift Gas. Int. J. Mass Spectrom. 427, 79–90 (2017).


35
Nichols, C. M., May, J. C., Sherrod, S. D. & McLean, J. A. Automated Flow Injection Method for the High Precision Determination of Drift Tube Ion Mobility Collision Cross Sections. Analyst 143, 1556–1559 (2018).


36
Davis, D. E. et al. Multidimensional Separations of Intact Phase II Steroid Metabolites Utilizing LC–Ion Mobility–HRMS. Anal. Chem. 93, 10990–10998 (2021).


ID Name Adduct Structure m/z CCS SMI Type Z Ref CCS Type CCS method
CCSBASE_BDBD9BFC08 LEVOCARNITINE [M+H]+ 162.1125 132.9 C[N+](C)(C)C[C@@H](CC(=O)[O-])O Organic nitrogen compounds 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_C61492AF8A METOCLOPRAMIDE HYDROCHLORIDE [M+H]+ 300.1474 171.8 CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC None 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_1379526A3B 1-MONOPALMITIN [M+Na]+ 353.2662 195.9 CCCCCCCCCCCCCCCC(=O)OCC(CO)O Lipids and lipid-like molecules 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_FC713A4917 HEPTAMINOL HYDROCHLORIDE [M+H-H2O]+ 128.1439 132.2 CC(N)CCCC(C)(C)O None 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_959BC65E78 CANAVANINE [M+H]+ 177.0982 133.3 C(CON=C(N)N)[C@@H](C(=O)O)N Organic acids and derivatives 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_83445168CB OCTODRINE [M+H]+ 130.159 134.7 CC(C)CCCC(C)N Organic nitrogen compounds 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_021C2A9F33 BATYL ALCOHOL [M+Na]+ 367.3182 202.8 CCCCCCCCCCCCCCCCCCOCC(CO)O Lipids and lipid-like molecules 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_AF263B24A0 NICARDIPINE HYDROCHLORIDE [M+H]+ 480.2129 211.9 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1 None 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_3963112DD4 URSOCHOLANIC ACID [M+H]+ 361.3101 169.3 C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCCC4)C)C Lipids and lipid-like molecules 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_3EBA9A105C HELENINE [M+H]+ 233.1536 149.5 C[C@H]1CCC[C@]2(C1=C[C@H]3[C@@H](C2)OC(=O)C3=C)C Lipids and lipid-like molecules 1 7 TW calibrated with polyalanine and drug standards
1 2 ... 296 297 298 299 300 301 302 ... 2501 2502